Eli Breuer

2.7k total citations
133 papers, 1.9k citations indexed

About

Eli Breuer is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Eli Breuer has authored 133 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Organic Chemistry, 37 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Eli Breuer's work include Organophosphorus compounds synthesis (50 papers), Bone health and treatments (26 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (22 papers). Eli Breuer is often cited by papers focused on Organophosphorus compounds synthesis (50 papers), Bone health and treatments (26 papers) and Synthesis and Reactivity of Sulfur-Containing Compounds (22 papers). Eli Breuer collaborates with scholars based in Israel, Germany and United States. Eli Breuer's co-authors include Gershon Golomb, Reuven Reich, Asher Ornoy, Terezinha de Jesus Andreoli Pinto, Rafik Karaman, Haim Leader, Shalom Sarel, Amiram Goldblum, Claudio J. Salomón and Sudhakar R. Bhusare and has published in prestigious journals such as Journal of the American Chemical Society, Biomaterials and Chemical Communications.

In The Last Decade

Eli Breuer

125 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Breuer Israel 24 931 542 462 180 170 133 1.9k
B.L. Barnett United States 23 474 0.5× 934 1.7× 615 1.3× 383 2.1× 81 0.5× 53 2.1k
B. A. Kashemirov United States 25 642 0.7× 780 1.4× 1.0k 2.2× 328 1.8× 66 0.4× 103 2.2k
Anusch Peyman Germany 22 1.1k 1.2× 252 0.5× 2.6k 5.7× 18 0.1× 98 0.6× 51 3.7k
James E. Dunford United Kingdom 27 445 0.5× 2.1k 3.8× 1.6k 3.6× 1.0k 5.7× 192 1.1× 54 3.6k
Donato Colangelo Italy 28 506 0.5× 741 1.4× 696 1.5× 18 0.1× 76 0.4× 74 2.0k
B Desoize France 19 322 0.3× 834 1.5× 640 1.4× 18 0.1× 150 0.9× 58 1.9k
Svetlana Gramatikova United States 10 304 0.3× 96 0.2× 823 1.8× 49 0.3× 27 0.2× 14 1.3k
Thomas L. Mindt Switzerland 33 1.5k 1.6× 952 1.8× 1.0k 2.2× 13 0.1× 38 0.2× 86 3.4k
Robert L. Jenkins United Kingdom 30 920 1.0× 110 0.2× 1.0k 2.2× 19 0.1× 533 3.1× 82 2.7k
Lurdes Gano Portugal 27 502 0.5× 720 1.3× 416 0.9× 9 0.1× 23 0.1× 131 2.1k

Countries citing papers authored by Eli Breuer

Since Specialization
Citations

This map shows the geographic impact of Eli Breuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Breuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Breuer more than expected).

Fields of papers citing papers by Eli Breuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Breuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Breuer. The network helps show where Eli Breuer may publish in the future.

Co-authorship network of co-authors of Eli Breuer

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Breuer. A scholar is included among the top collaborators of Eli Breuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Breuer. Eli Breuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohrisch, J., Christian Schmidt, Eli Breuer, et al.. (2020). The Effect of Chemical Modifications of Chitosan on Intestinal Permeability and Oral Bioavailability of Carbamoylphosphonate JS403. Journal of Bioequivalence & Bioavailability. 12(2). 1–8. 3 indexed citations
2.
Nedvetzki, Shlomo, et al.. (2011). Orally Active, Antimetastatic, Nontoxic Diphenyl Ether‐Derived Carbamoylphosphonate Matrix Metalloproteinase Inhibitors. ChemMedChem. 6(8). 1471–1477. 11 indexed citations
3.
Breuer, Eli, Mukund S. Chorghade, Itzhak Fischer, & Gershon Golomb. (2009). Glossary of terms related to pharmaceutics (IUPAC Recommendations 2009). Pure and Applied Chemistry. 81(5). 971–999. 7 indexed citations
4.
5.
Osipov, Sergey N., et al.. (2006). Methyltrifluoropyruvate imines possessing N-oxalyl and N-phosphonoformyl groups—precursors to a variety of α-CF3-α-amino acid derivatives. Organic & Biomolecular Chemistry. 4(19). 3669–3674. 26 indexed citations
6.
Breuer, Eli, Claudio J. Salomón, Weibin Chen, et al.. (2004). Carbamoylphosphonates, a New Class of in Vivo Active Matrix Metalloproteinase Inhibitors. 1. Alkyl- and Cycloalkylcarbamoylphosphonic Acids. Journal of Medicinal Chemistry. 47(11). 2826–2832. 39 indexed citations
7.
Farkas, Etelka, et al.. (2004). Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group. JBIC Journal of Biological Inorganic Chemistry. 9(3). 307–315. 47 indexed citations
8.
9.
Golomb, Gershon, et al.. (1999). Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 60(2). 68–73. 146 indexed citations
10.
Cohen, Hagit, Vered Solomon, Ivan S. Alferiev, et al.. (1998). Bisphosphonates and Tetracycline: Experimental Models for Their Evaluation in Calcium-Related Disorders. Pharmaceutical Research. 15(4). 606–613. 30 indexed citations
11.
Breuer, Eli, Asher Ornoy, Jukka Mönkkönen, et al.. (1997). In Vitro and In Vivo Effects of Tetrakisphosphonates on Bone Resorption, Tumor Osteolysis, Ectopic Calcification, and Macrophages. Journal of Pharmaceutical Sciences. 86(3). 283–289. 12 indexed citations
12.
Breuer, Eli, et al.. (1995). Anticalcification and antiresorption effects of bisacylphosphonates. Bone. 16(5). 511–520. 40 indexed citations
13.
Golomb, Gershon, et al.. (1992). Bisacylphosphonates Inhibit Hydroxyapatite Formation and Dissolution in Vitro and Dystrophic Calcification in Vivo. Pharmaceutical Research. 9(1). 143–148. 41 indexed citations
14.
Golomb, Gershon, et al.. (1992). In Vitro and In Vivo Anticalcification Effects of Novel Bishydroxyiminophosphonates. Journal of Pharmaceutical Sciences. 81(10). 1004–1007. 17 indexed citations
15.
Chorev, Michael, et al.. (1990). Aminoacylphosphonates-Novel Modified Amino Acid Derivatives. Phosphorus, sulfur, and silicon and the related elements. 51(1-4). 396–396.
16.
Breuer, Eli, Hans Günter Aurich, & Arnold T. Nielsen. (1989). Nitrones, Nitronates and Nitroxides (1989). Medical Entomology and Zoology. 61 indexed citations
17.
Brown, Nesbitt D., et al.. (1988). Desethylaprophen: A Metabolite of Aprophen with Antimuscarinic Activities*. Journal of Pharmaceutical Sciences. 77(2). 145–148. 1 indexed citations
18.
Breuer, Eli, Rafik Karaman, Amiram Goldblum, et al.. (1988). α-Oxyiminophosphonates: chemical and physical properties. Reactions, theoretical calculations, and X-ray crystal structures of (E) and (Z)-dimethyl α-hydroxyiminobenzylphosphonates. Journal of the Chemical Society Perkin Transactions 1. 3047–3057. 31 indexed citations
19.
Breuer, Eli, Rafik Karaman, Haim Leader, & Amiram Goldblum. (1987). Phosphorylation of alcohols through the acid-catalysed fragmentation of α-oxyiminophosphonates. Journal of the Chemical Society Chemical Communications. 671–672. 11 indexed citations
20.
Breuer, Eli & Shmuel Zbáida. (1977). Nitrones. 4. Reactions of .DELTA.1-pyrroline N-oxides with phosphonates. Alternative formation of aziridines and enamines. The Journal of Organic Chemistry. 42(11). 1904–1910. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B.L. Barnett Breakdown of academic impact, for papers by B. A. Kashemirov Breakdown of academic impact, for papers by Anusch Peyman Breakdown of academic impact, for papers by James E. Dunford Breakdown of academic impact, for papers by Donato Colangelo Breakdown of academic impact, for papers by B Desoize Breakdown of academic impact, for papers by Svetlana Gramatikova Breakdown of academic impact, for papers by Thomas L. Mindt Breakdown of academic impact, for papers by Robert L. Jenkins Breakdown of academic impact, for papers by Lurdes Gano
Rankless by CCL
2026